China Next-Gen Commerce and Supply Chain Limited (HKG:3928)

G1 Therapeutics Income Statement

Financials in millions SGD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	64.3	55.97	56.06	67.09	47.43	41.52
Revenue Growth (YoY)	34.54%	-0.15%	-16.45%	41.46%	14.22%	-52.32%
Cost of Revenue	59.42	51.17	52.25	63.88	52.46	43.56
Gross Profit	4.89	4.8	3.81	3.22	-5.03	-2.04
Selling, General & Admin	4.99	5.02	4.78	8.2	8.71	4.87
Operating Expenses	6.12	5.84	7.02	7.94	8.58	6.71
Operating Income	-1.23	-1.04	-3.21	-4.73	-13.62	-8.75
Interest Expense	-0.81	-0.91	-1	-1.21	-1.27	-1.26
Interest & Investment Income	0.02	0.03	0.02	0	0	0
Earnings From Equity Investments	-0	-0	-0.58	-0.53	0.04	-0.06
Currency Exchange Gain (Loss)	-0.09	-0.44	-0.34	0.3	-0.11	-0.06
Other Non Operating Income (Expenses)	0.5	0.48	0.64	1.01	1.17	0.11
EBT Excluding Unusual Items	-1.62	-1.89	-4.46	-5.15	-13.79	-10.01
Gain (Loss) on Sale of Assets	0.06	0.16	2.97	3.01	0.93	0.65
Asset Writedown	0.91	0.91	0.15	0.24	-0.1	-0.14
Other Unusual Items	0.02	0.03	0.02	0.36	1.1	2.34
Pretax Income	-0.62	-0.78	-1.28	-1.45	-11.33	-7.16
Income Tax Expense	-	-	-0.24	0.04	-0.14	-0.07
Net Income	-0.62	-0.78	-1.04	-1.49	-11.19	-7.09
Net Income to Common	-0.62	-0.78	-1.04	-1.49	-11.19	-7.09
Shares Outstanding (Basic)	480	480	480	480	480	480
Shares Outstanding (Diluted)	480	480	480	480	480	480
Shares Change (YoY)	-	-	-	-	-	31.89%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.02	-0.01
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.02	-0.01
Free Cash Flow	2.12	1.22	1.41	1.39	1.46	-6.4
Free Cash Flow Per Share	0.00	0.00	0.00	0.00	0.00	-0.01
Gross Margin	7.60%	8.57%	6.79%	4.79%	-10.61%	-4.92%
Operating Margin	-1.92%	-1.85%	-5.73%	-7.04%	-28.71%	-21.07%
Profit Margin	-0.97%	-1.40%	-1.85%	-2.23%	-23.60%	-17.07%
Free Cash Flow Margin	3.29%	2.18%	2.51%	2.07%	3.07%	-15.41%
EBITDA	0.5	0.78	-1.91	-3.23	-12.27	-5.18
EBITDA Margin	0.78%	1.40%	-3.41%	-4.82%	-25.86%	-12.48%
D&A For EBITDA	1.74	1.82	1.3	1.49	1.35	3.57
EBIT	-1.23	-1.04	-3.21	-4.73	-13.62	-8.75
EBIT Margin	-1.92%	-1.85%	-5.73%	-7.04%	-28.71%	-21.07%
Revenue as Reported	64.3	55.97	56.06	67.09	47.43	41.52

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.